CT灌注成像选择对血管内治疗大血管闭塞性卒中临床结局的影响
本研究基于前瞻性注册登记数据,比较CT灌注成像(CTP)与非增强CT单独选择前循环卒中患者行支架取栓的90天改良Rankin量表(mRS)变化。共纳入602例,CTP选择365例(61%),与更优的90天mRS偏移相关(aOR=1.49;95%CI 1.06-2.09;P=0.02),良好预后率更高(52.9% vs 40.4%;P=0.005),死亡率更低(16.6% vs 26.8%;P=0.005)。
要点
- CTP选择与支架取栓后90天mRS良好偏移独立相关(aOR=1.49;95%CI 1.06-2.09)。
- CTP组良好预后(mRS 0-2)率52.9% vs 40.4%,死亡率16.6% vs 26.8%。
- 发病>6小时或ASPECTS≤7时,CTP对功能结局预测更优。
核心结论
- CTP选择与支架取栓患者90天mRS良好偏移相关。
研究设计与样本
- 回顾性分析2010年9月至2016年3月单中心前瞻性注册登记的前循环卒中行支架取栓患者,共602例,比较CTP选择与非增强CT单独选择。
主要发现
- CTP选择组(n=365,61%)较非CTP组年轻(P=0.02)且合并症更少。
- CTP选择与90天mRS良好偏移相关(aOR=1.49;95%CI 1.06-2.09;P=0.02)。
- CTP组90天mRS 0-2比例52.9% vs 40.4%(P=0.005),mTICI-3再灌注54.8% vs 40.1%(P<0.001),最终梗死体积24.7 mL(9.8-63.1 mL)vs 34.6 mL(13.1-88 mL)(P=0.017),死亡率16.6% vs 26.8%(P=0.005)。
- 按年龄、NIHSS评分和血糖匹配(n=424)后,CTP仍与90天mRS良好偏移(P=0.016)、更低死亡率(P=0.02)和更高再灌注率(P<0.001)相关。
- 发病>6小时患者中,CTP预测功能结局更优(AIC 199.35 vs 287.49;BIC 196.71 vs 283.27);ASPECTS≤7患者中亦更优(AIC 216.69 vs 334.96;BIC 213.6 vs 329.94)。
临床怎么用
- 在支架取栓患者选择中,可考虑使用CTP以改善功能结局和降低死亡率。
局限性
- 本研究为单中心注册登记回顾性分析,需前瞻性研究进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND PURPOSE: Different imaging paradigms have been used to select patients for endovascular therapy in stroke. We sought to determine whether computed tomographic perfusion (CTP) selection improves endovascular therapy outcomes compared with noncontrast computed tomography alone. METHODS: Review of a prospectively collected registry of anterior circulation stroke patients undergoing stent-retriever thrombectomy at a tertiary care center between September 2010 and March 2016. Patients undergoing CTP were compared with those with noncontrast computed tomography alone. The primary outcome was the shift in the 90-day modified Rankin scale (mRS). RESULTS: A total of 602 patients were included. CTP-selected patients (n=365, 61%) were younger (P=0.02) and had fewer comorbidities. CTP selection (n=365, 61%) was associated with a favorable 90-day mRS shift (adjusted odds ratio [aOR]=1.49; 95% confidence interval [CI], 1.06-2.09; P=0.02), higher rates of good outcomes (90-day mRS score 0-2: 52.9% versus 40.4%; P=0.005), modified Thrombolysis in Cerebral Infarction-3 reperfusion (54.8% versus 40.1%; P<0.001), smaller final infarct volumes (24.7 mL [9.8-63.1 mL] versus 34.6 mL [13.1-88 mL]; P=0.017), and lower mortality (16.6% versus 26.8%; P=0.005). When matched on age, National Institutes of Health Stroke Scale (NIHSS) score, and glucose (n=424), CTP remained associated with a favorable 90-day mRS shift (P=0.016), lower mortality (P=0.02), and higher rates of reperfusion (P<0.001). CTP better predicted functional outcomes in patients presenting after 6 hours (as assessed by comparison of logistic regression models: Akaike information criterion: 199.35 versus 287.49 and Bayesian information criterion: 196.71 versus 283.27) and those with an Alberta Stroke Program Early Computed Tomography Score ≤7 (Akaike information criterion: 216.69 versus 334.96 and Bayesian information criterion: 213.6 versus 329.94). CONCLUSIONS: CTP selection is associated with a favorable mRS shift in patients undergoing stent-retriever thrombectomy. Future prospective studies are warranted.
引用
- Bouslama M, Haussen DC, Grossberg JA, et al. Computed Tomographic Perfusion Selection and Clinical Outcomes After Endovascular Therapy in Large Vessel Occlusion Stroke. Stroke. 2017. PMID: 28389614. doi:10.1161/STROKEAHA.116.015636
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。